论文部分内容阅读
目的:观察多潘立酮联合香砂养胃丸治疗功能性消化不良的临床疗效。方法:以90例功能性消化不良患者为研究对象,将其随机分为对照组与实验组各45例。对照组仅采用多潘立酮治疗,实验组采用多潘立酮联合香砂养胃丸治疗,对比两组患者临床疗效。结果:实验组患者蛋白酶、肠道消化酶及胃肠激素的回归均优于对照组,检测结果为蛋白酶(52.12±2.10)U/L、肠道消化酶(86.10±5.18)g/L、肠道激素(23.12±2.16)μmol/L,而对照组则分别为(32.13±2.17)U/L、(73.25±3.10)g/L、(19.12±1.14)μmol/L,两组差异有统计学意义(P<0.05)。结论:多潘立酮联合香砂养胃丸治疗功能性消化不良效果显著,值得临床推广使用。
Objective: To observe the clinical efficacy of domperidone combined Xiangsha Yangwei Wan in the treatment of functional dyspepsia. Methods: Ninety patients with functional dyspepsia were randomly divided into control group and experimental group (45 cases each). The control group only domperidone treatment, the experimental group with domperidone combined Xiangshayangwei pills treatment, the clinical efficacy of two groups were compared. Results: The regression of protease, gut digestive enzymes and gut hormones in the experimental group were better than those in the control group. The test results were as follows: protease (52.12 ± 2.10) U / L, intestinal digestive enzyme (86.10 ± 5.18) g / L, (23.12 ± 2.16) μmol / L respectively, while the control group was (32.13 ± 2.17) U / L, (73.25 ± 3.10) g / L and (19.12 ± 1.14) μmol / L respectively Significance (P <0.05). Conclusion: Domperidone combined with Xiangshayangwei Pill has significant effect on functional dyspepsia, which is worthy of clinical promotion.